Aurobindo Pharma Limited, a key player in the global pharmaceuticals market, has once again demonstrated remarkable financial health in the first quarter of fiscal year 2025. The company announced a 10.5% increase in revenue from operations, totaling INR 7,567 crore. This surge is attributed to consistent growth across all business sectors, particularly in the United […]
In a significant development for the pharmaceutical industry, Aurobindo Pharma Limited has announced receiving the final nod from the United States Food and Drug Administration (USFDA) to manufacture and market Fingolimod Capsules, 0.5 mg. This approval marks a crucial milestone, as these capsules are recognized as bioequivalent and therapeutically equivalent to the reference listed drug, […]
